China NT Pharma Group Company Limited

HKEX:1011.HK

0.335 (HKD) • At close May 9, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.

2024 Q42024 Q22023 Q22022 Q42022 Q22021 Q42021 Q22020 Q22019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42010 Q2
Omzet 6.66331.2977.36686.591120.501115.466111.23389.43694.0230311.9850314.3990385.789466.823380.903456.522408.099227.851526.264369.566369.5661,379.0711,379.0711,333.9891,333.989
Kosten van de omzet 7.10925.59130.30636.17645.6341.66839.57232.73832.786070.844085.3250229.046195.519200.7229.69243.59129.526335.621233.657233.657933.748933.7481,002.3881,002.388
Brutowinst -0.4465.706-22.9450.41574.87173.79871.66156.69861.2370241.1410229.0740156.743271.304180.203226.832164.50998.325190.643135.91135.91445.323445.323331.602331.602
Brutowinstmarge -0.0670.182-3.1140.5820.6210.6390.6440.6340.65100.77300.72900.4060.5810.4730.4970.4030.4320.3620.3680.3680.3230.3230.2490.249
Onderzoek- en ontwikkelingskosten 0003.76205.9590000000004.47700000000000
Algemene en administratieve kosten 11.4417.04510.10933.54726.33143.15636.17544.40337.981051.693050.309028.46466.12324.53146.22126.87767.4845.23164.64964.64964.54164.54145.02845.028
Verkoop- en marketingkosten 0.0550.05511.0392.5148.74997.42252.44138.42641.048050.043046.225072.939138.9789.929138.857125.726135.291240.516289.913289.913226.417226.417177.228177.228
Verkoop-, algemene en administratieve kosten 11.3867.110.10931.28875.08150.31788.61682.82979.0290101.77096.9960102.799220.91119.635164.357152.603181.275285.747354.562354.562290.958290.958222.256222.256
Overige kosten 0000000000000000000000.1120.112-28.411-28.411-18.423-18.423
Bedrijfskosten 11.3867.110.10940.57767.295162.16443.55979.1585.374099.854088.158098.64205.878124.004181.994135.047268.895624.556353.499353.499262.547262.547203.833203.833
Bedrijfsresultaat -11.832-1.394-2.74319.154-0.236-76.665-16.809-24.664-22.2420138.7190141.604057.8976.85860.61644.0534.439-80.195-94.567-558.595-558.595182.776182.776127.769127.769
Bedrijfsresultaat ratio -1.776-0.045-0.3720.221-0.002-0.664-0.151-0.276-0.23700.44500.4500.150.1650.1590.0960.084-0.352-0.18-1.511-1.5110.1330.1330.0960.096
Totaal overige inkomsten en kosten netto -42.4332.179-2.053-46.161-34.872-68.493-31.904-27.047-22.1850-26.290-29.5830-8.014-16.232-19.02-42.344-36.4-111.125-366.954-30.049-30.049-29.042-29.042-22.69-22.69
Inkomen voor belasting -54.2650.785-4.796-27.007-27.289-145.158-3.594-48.499-44.4270116.1940111.402054.03462.54438.16114.1823.145-191.32-461.521-588.644-588.644153.735153.735105.079105.079
Inkomen voor belasting ratio -8.1440.025-0.651-0.312-0.226-1.257-0.032-0.542-0.47300.37200.35400.140.1340.10.0310.008-0.84-0.877-1.593-1.5930.1110.1110.0790.079
Belastingkosten 0.2470.1240.81611.160.9492.582-0.94-1.7540.05010.29709.01303.96611.341.67114.3890.85150.05229.435-33.986-33.98636.54636.54640.37440.374
Nettowinst -54.0180.661-5.612-38.167-28.238-146.884-2.654-46.745-43.4260104.5080102.884050.06851.20436.49-0.2072.294-241.372-432.086-554.658-554.658117.189117.18964.30564.305
Nettowinstmarge -8.1070.021-0.762-0.441-0.234-1.272-0.024-0.523-0.46200.33500.32700.130.110.096-00.006-1.059-0.821-1.501-1.5010.0850.0850.0480.048
WPA (Winst Per Aandeel) -0.20-0.003-0.02-0.015-0.078-0.001-0.025-0.02600.05600.06500.0320.0330.028-00.002-0.22-0.4-0.51-0.510.120.120.080.08
Verwaterde WPA -0.20-0.003-0.02-0.015-0.078-0.001-0.025-0.02600.05600.06500.0320.0330.028-00.002-0.22-0.4-0.51-0.510.120.120.080.08
EBITDA -7.263-1.387-2.5626.4939.582-54.342-2.928-14.472-13.6470149.6770150.24067.59484.21168.3858.86346.721-65.790-548.723-548.723194.898194.898136.481136.481
EBITDA ratio -1.09-0.044-0.3480.3060.08-0.471-0.026-0.162-0.14500.4800.47800.1750.180.180.1290.114-0.2890-1.485-1.4850.1410.1410.1020.102